The introduction of fluorine atoms into organic molecules can significantly alter their pharmacokinetic properties, such as metabolic stability, lipophilicity, and binding affinity. This makes fluorinated compounds highly sought after in pharmaceutical research and development. Among these valuable molecules is 2-(5-Bromo-2-Methylbenzyl)-5-(4-fluorophenyl)thiophene (CAS: 1030825-20-7), a key intermediate featuring a strategically placed fluorine atom.

This specific intermediate is instrumental in the synthesis of Canagliflozin, an antidiabetic drug. The fluorophenyl moiety within its structure contributes to the overall efficacy and pharmacological profile of the final active pharmaceutical ingredient (API). For R&D scientists and formulators, understanding the impact of such structural features is crucial for optimizing drug performance and exploring new therapeutic avenues.

As a dedicated manufacturer and supplier of specialized organic chemicals, we provide 2-(5-Bromo-2-Methylbenzyl)-5-(4-fluorophenyl)thiophene to the global pharmaceutical industry. Our expertise in handling complex synthesis, including the incorporation of fluorinated groups, ensures that we deliver a product of the highest quality. We are committed to supporting the innovation pipeline by making these essential building blocks readily available.

For those looking to procure this intermediate, we offer transparent pricing and flexible ordering options. Whether you are a procurement manager looking for stable supply or a research scientist requiring precise specifications for your synthesis, we are your go-to manufacturer. Engaging with us means partnering with a reliable supplier that understands the nuanced demands of modern drug development. Contact us to learn more about how our high-purity fluorinated intermediates can benefit your projects and to secure a quotation.